{"meta":{"query_hash":"6af7a4e2da64","filters":{"venue":"Journal of Ocular Pharmacology and Therapeutics"},"cohort_total":34,"direct_labels_cover":0,"predictions_cover":34,"exported":34,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6af7a4e2da64","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Ocular+Pharmacology+and+Therapeutics"},"results":[{"id":"W1480657560","doi":"10.1089/jop.2013.0108","title":"A Randomized, Prospective Study of Bimatoprost 0.01% or Travoprost/Timolol in Patients Previously Treated with Latanoprost and Timolol to Reduce Intraocular Pressure","year":2013,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"","keywords":"Bimatoprost; Travoprost; Timolol; Latanoprost; Intraocular pressure; Medicine; Ophthalmology; Glaucoma; Dorzolamide; Tolerability; Crossover study; Anesthesia; Adverse effect; Internal medicine; Placebo","score_opus":0.009722842690639753,"score_gpt":0.28693110111899955,"score_spread":0.2772082584283598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480657560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956196,0.00091879437,0.00034068254,0.00018772535,0.00029090032,0.0018935439,0.00021430058,0.000030774863,0.0005036926],"genre_scores_gemma":[0.9929779,0.0007476182,0.0014260537,0.0006224931,0.000573526,0.0022073097,0.0004003903,0.000012691218,0.0010320009],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99831116,0.0009170435,0.00014406722,0.00027692274,0.00014452725,0.00020626998],"domain_scores_gemma":[0.9977062,0.0007543699,0.00046220495,0.00021485498,0.0001557697,0.0007066241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029984857,0.0013118958,0.002897438,0.00045866496,0.00062141626,0.0009758264,0.00085800985,0.0017356061,0.004930339],"category_scores_gemma":[0.0031432915,0.0011300762,0.002037048,0.0004407806,0.001545974,0.0008543387,0.0003662839,0.0021379152,0.0009270197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.969529,0.016402809,0.0025548555,0.00014857539,0.0004930522,0.0000607236,0.000054426313,0.000106813975,0.004105208,0.000045932367,0.00017825051,0.006320455],"study_design_scores_gemma":[0.80924606,0.18544532,0.004059404,0.0000106311245,0.00036982322,0.00003909676,0.000021321308,0.00019847268,0.00030903897,0.000037718833,0.00024996465,0.000013178627],"about_ca_topic_score_codex":0.000838704,"about_ca_topic_score_gemma":0.0018982585,"teacher_disagreement_score":0.004930339,"about_ca_system_score_codex":0.00053523004,"about_ca_system_score_gemma":0.0015466287,"threshold_uncertainty_score":0.016493678},"labels":[],"label_agreement":null},{"id":"W1969980370","doi":"10.1089/jop.2013.0002","title":"Comparison of the Effects of Ophthalmic Solutions on Human Corneal Epithelial Cells Using Fluorescent Dyes","year":2013,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Corneal Surgery and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Benzalkonium chloride; Fluorescein; Viability assay; Confocal microscopy; Chemistry; Preservative; Barrier function; Fluorescence microscope; Biochemistry; Pharmacology; Biophysics; Cell; Chromatography; Fluorescence; Biology; Cell biology","score_opus":0.06989094392957393,"score_gpt":0.3848107726948315,"score_spread":0.3149198287652576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969980370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98677176,0.011286925,0.00073206227,0.000086463784,0.0000610802,0.000031227075,0.00010365883,0.000010794608,0.000915971],"genre_scores_gemma":[0.9902193,0.0061520115,0.0022327097,0.00011672351,0.000024042643,0.00004465779,0.00019077145,0.000008780082,0.0010110618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995441,0.000105321866,0.00006475691,0.00006268936,0.00015531118,0.000067896],"domain_scores_gemma":[0.99970776,0.00006905344,0.000075866774,0.000031129748,0.00009255734,0.00002352077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038215274,0.0005008939,0.00033323906,0.00028985782,0.0002808047,0.000475318,0.00018058435,0.0004519269,0.0009554893],"category_scores_gemma":[0.00057133095,0.00013512901,0.00046019358,0.00030194974,0.00027235007,0.0004240426,0.00028937875,0.00036726502,0.00011682684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009797526,0.00010217322,0.0013611758,0.00029539774,0.000036106267,0.0001200256,0.000089485395,0.000100748824,0.9899608,0.00006715857,0.00006647232,0.0068207164],"study_design_scores_gemma":[0.000026556369,0.0020165688,0.01077272,0.000034422515,0.000101648075,0.00029972746,0.00022392273,0.00035879883,0.983932,0.000026987898,0.0021930067,0.000013535948],"about_ca_topic_score_codex":0.0024324143,"about_ca_topic_score_gemma":0.0027410174,"teacher_disagreement_score":0.0024324143,"about_ca_system_score_codex":0.0004287445,"about_ca_system_score_gemma":0.00039437725,"threshold_uncertainty_score":0.0048364997},"labels":[],"label_agreement":null},{"id":"W2003003843","doi":"10.1089/jop.2006.22.160","title":"Ocular Hypotensive Effects of an Intratracheally Delivered Liposomal Δ9-Tetrahydrocannabinol Preparation in Rats","year":2006,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada; Dalhousie University","funders":"","keywords":"Intraocular pressure; Antagonist; ED50; Chemistry; Pharmacology; Tetrahydrocannabinol; Δ9-tetrahydrocannabinol; Medicine; Anesthesia; Cannabinoid; Ophthalmology; Internal medicine; Receptor","score_opus":0.00829350048591176,"score_gpt":0.31104643483906386,"score_spread":0.3027529343531521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003003843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963336,0.0017741317,0.0010371596,0.00010483781,0.00005581264,0.000040780866,0.00012531741,0.00004377936,0.00048453538],"genre_scores_gemma":[0.9920719,0.0032417201,0.0019497938,0.00011842117,0.000032741493,0.00007698306,0.00022482873,0.000014268697,0.0022693097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999018,0.000011287138,0.000008049025,0.000022243896,0.000027292286,0.000029280125],"domain_scores_gemma":[0.9998605,0.000015226135,0.000042869724,0.000015017691,0.000023316645,0.000042968448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013009073,0.00047105155,0.0004547386,0.00031143156,0.00017032036,0.0002041975,0.00019076296,0.0003834374,0.00082277553],"category_scores_gemma":[0.00015615483,0.00018042514,0.00025216246,0.00016226675,0.0004124683,0.00037910673,0.00016674752,0.0007875751,0.00025640873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012398101,0.00013623522,0.00009850186,0.000064997,0.000013999304,0.00006753142,0.00002053011,0.00006625292,0.99536765,0.000030957617,0.000034510107,0.0028590164],"study_design_scores_gemma":[0.00011563427,0.005488439,0.001813366,0.000009413546,0.00005842025,0.00012317153,0.00007338374,0.00032007034,0.991113,0.000026689257,0.00084692147,0.000011504221],"about_ca_topic_score_codex":0.0017479224,"about_ca_topic_score_gemma":0.0029110806,"teacher_disagreement_score":0.0017479224,"about_ca_system_score_codex":0.00035423454,"about_ca_system_score_gemma":0.00045250083,"threshold_uncertainty_score":0.0034754872},"labels":[],"label_agreement":null},{"id":"W2006935174","doi":"10.1089/jop.2006.22.389","title":"Serotonin-2 (5-HT <sub>2</sub> ) Receptor-Mediated Signal Transduction in Human Ciliary Muscle Cells: Role in Ocular Hypotension","year":2006,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Waterloo; McMaster University","keywords":"Receptor; Serotonin; Agonist; Tryptamine; Ketanserin; Ciliary body; 5-HT receptor; Chemistry; Receptor antagonist; Endocrinology; Molecular biology; Internal medicine; Pharmacology; Biology; Antagonist; Biochemistry; Medicine","score_opus":0.008227173150656244,"score_gpt":0.250479799962157,"score_spread":0.24225262681150078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006935174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281526,0.004626553,0.0012508519,0.00007656552,0.000009558646,0.000023909985,0.00014763755,0.000019903071,0.0010298053],"genre_scores_gemma":[0.99661535,0.0011928434,0.0010359864,0.000057756333,0.0000120275445,0.000032735876,0.00021899672,0.0000032246505,0.0008311493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993825,0.000011579738,0.000005344843,0.000014076777,0.000013700805,0.000017072176],"domain_scores_gemma":[0.99995637,0.000011428656,0.000010609851,0.0000058921705,0.000007086137,0.000008631995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099575416,0.00017631373,0.00018861571,0.0001585724,0.00016378846,0.00023645752,0.00009737366,0.00027214034,0.0012624826],"category_scores_gemma":[0.000092625734,0.000110176,0.00015743356,0.0001230821,0.00016834347,0.00011568503,0.00011318698,0.00017363849,0.0002840786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018944016,0.0000072964017,0.0016965711,0.000035043544,0.0000050852154,0.00018309726,0.000032872955,0.000014293292,0.9961599,0.000026346639,0.000021007294,0.0016290508],"study_design_scores_gemma":[0.000055297063,0.0010487051,0.23660855,0.000018367838,0.00009346044,0.0022880542,0.00028915083,0.001034099,0.7561256,0.00006112946,0.0023676585,0.000009965139],"about_ca_topic_score_codex":0.002305973,"about_ca_topic_score_gemma":0.0028460948,"teacher_disagreement_score":0.002305973,"about_ca_system_score_codex":0.00021391224,"about_ca_system_score_gemma":0.0001621138,"threshold_uncertainty_score":0.004585147},"labels":[],"label_agreement":null},{"id":"W2009113844","doi":"10.1089/jop.2010.0135","title":"Ocular Penetration and Anti-inflammatory Activity of Ketorolac 0.45% and Bromfenac 0.09% Against Lipopolysaccharide-Induced Inflammation","year":2011,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"Allergan","keywords":"Ketorolac; Pharmacology; Prostaglandin E2; Cyclooxygenase; Prostaglandin; Medicine; Chemistry; Lipopolysaccharide; Inflammation; Anesthesia; Analgesic; Endocrinology; Internal medicine; Biochemistry; Enzyme","score_opus":0.02970277810786373,"score_gpt":0.2888886293263546,"score_spread":0.2591858512184909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009113844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963883,0.0026269876,0.0004240509,0.000046704983,0.000022773937,0.000029065874,0.000056817815,0.000016393631,0.0003888856],"genre_scores_gemma":[0.9961851,0.0019037162,0.0009660255,0.00004977057,0.00002356207,0.000037926482,0.00012332192,0.0000057341954,0.000704963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999658,0.000058560967,0.000037517995,0.0000486061,0.000094315554,0.000103100676],"domain_scores_gemma":[0.9997003,0.000035570967,0.00011742076,0.000026329133,0.00003867597,0.00008175189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029169107,0.00045252958,0.00042393204,0.00029822133,0.0001510199,0.0002546847,0.0002000701,0.00032479395,0.00094573305],"category_scores_gemma":[0.00027451722,0.0001983396,0.0004537165,0.0001414935,0.0003502866,0.00049627334,0.00016047357,0.0005196913,0.0001960095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003206107,0.00032830943,0.0006495578,0.00010102697,0.000021178586,0.000057032903,0.000035578814,0.00006528418,0.99050003,0.00003990247,0.000036619953,0.004959412],"study_design_scores_gemma":[0.00029446837,0.0260729,0.011856091,0.000018278874,0.00008739578,0.0004305473,0.00010197402,0.00054662855,0.9591496,0.000029221454,0.0013992977,0.000013670048],"about_ca_topic_score_codex":0.0009896391,"about_ca_topic_score_gemma":0.0012719035,"teacher_disagreement_score":0.0009896391,"about_ca_system_score_codex":0.0002800064,"about_ca_system_score_gemma":0.0004137371,"threshold_uncertainty_score":0.0031638145},"labels":[],"label_agreement":null},{"id":"W2016660338","doi":"10.1089/jop.2005.21.36","title":"Comparison of Ophthalmic Gatifloxacin 0.3% and Ciprofloxacin 0.3% in Healing of Corneal Ulcers Associated with <i>Pseudomonas aeruginosa</i> –Induced Ulcerative Keratitis in Rabbits","year":2005,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Québec International","funders":"","keywords":"Gatifloxacin; Ciprofloxacin; Medicine; Pseudomonas aeruginosa; Keratitis; Cornea; Ofloxacin; Ophthalmology; Dosing; Pharmacology; Antibiotics; Microbiology; Bacteria; Biology","score_opus":0.03693791124385739,"score_gpt":0.3624855665103441,"score_spread":0.3255476552664867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016660338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742967,0.0018550506,0.00019725894,0.000039247945,0.000021712758,0.000032474694,0.000046366025,0.00001659197,0.00036158002],"genre_scores_gemma":[0.99648064,0.0017323032,0.00091377326,0.000074595366,0.000031775155,0.00005618443,0.0001261836,0.0000076256447,0.0005769417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996798,0.00006596762,0.00004875275,0.000042245298,0.000073539726,0.000089765344],"domain_scores_gemma":[0.9995592,0.000057729118,0.00015253831,0.000023429007,0.000056625602,0.00015050574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040629334,0.00043265044,0.0005246123,0.0005251041,0.00018144923,0.00029785564,0.00033329404,0.0005796164,0.00043223985],"category_scores_gemma":[0.00036372963,0.00025698144,0.00040654422,0.00021707347,0.00039031258,0.00036089306,0.00012818139,0.00039942894,0.00015766971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011846941,0.0011094159,0.0014164308,0.00029179206,0.000046459412,0.00011366931,0.000083797706,0.00017849842,0.9703719,0.00006822016,0.00010926165,0.014363448],"study_design_scores_gemma":[0.0017833421,0.11662119,0.028997635,0.00006906437,0.00030570372,0.00066769286,0.00025089993,0.0012143628,0.847511,0.000088966386,0.0024377848,0.000052446987],"about_ca_topic_score_codex":0.0011020383,"about_ca_topic_score_gemma":0.0018069097,"teacher_disagreement_score":0.0011020383,"about_ca_system_score_codex":0.00031810778,"about_ca_system_score_gemma":0.00037264675,"threshold_uncertainty_score":0.0023080707},"labels":[],"label_agreement":null},{"id":"W2027138344","doi":"10.1089/108076803762718105","title":"Hydrolysis of Bimatoprost (Lumigan) to its Free Acid by Ocular Tissue <i>In Vitro</i>","year":2003,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Bimatoprost; Ciliary body; Sclera; Cornea; Chemistry; Agonist; Prodrug; Hydrolysis; Receptor; In vitro; Pharmacology; Ophthalmology; Biochemistry; Ocular hypertension; Medicine; Intraocular pressure","score_opus":0.04990556788287313,"score_gpt":0.3827400223956901,"score_spread":0.33283445451281696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027138344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854042,0.004681714,0.0064158626,0.0000657818,0.000024807629,0.000049386184,0.0003182944,0.000059792404,0.0029801626],"genre_scores_gemma":[0.98458797,0.002683152,0.008110434,0.00011318754,0.000026953145,0.00006040216,0.0007539046,0.000024229681,0.0036397474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998555,0.000039293824,0.0000068813642,0.00003677585,0.000034013887,0.00002749757],"domain_scores_gemma":[0.9999064,0.000029133083,0.000027949014,0.000009824866,0.0000112981315,0.000015421083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021561507,0.00036500877,0.00021368779,0.00018976428,0.00014080117,0.0002857761,0.00011955491,0.00022361308,0.001590277],"category_scores_gemma":[0.000257104,0.00011899021,0.00016833031,0.00012967942,0.00026266472,0.00025019248,0.00018043356,0.00026236888,0.00045915926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028869987,0.00001740902,0.00081732677,0.000059055088,0.0000076292135,0.000072840725,0.000017079676,0.000055440734,0.99413294,0.00006043018,0.00003554181,0.0044356124],"study_design_scores_gemma":[0.000008179734,0.00078744686,0.0055309027,0.0000059694526,0.000015752303,0.00027706896,0.000031588675,0.00050403445,0.991642,0.000030101937,0.0011633971,0.000003718889],"about_ca_topic_score_codex":0.0009862501,"about_ca_topic_score_gemma":0.0012486516,"teacher_disagreement_score":0.001590277,"about_ca_system_score_codex":0.0002947407,"about_ca_system_score_gemma":0.00032180757,"threshold_uncertainty_score":0.0053200126},"labels":[],"label_agreement":null},{"id":"W2041345658","doi":"10.1089/jop.2009.0023","title":"Pycnogenol <sup>®</sup> Improves Microcirculation, Retinal Edema, and Visual Acuity in Early Diabetic Retinopathy","year":2009,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"","keywords":"Medicine; Retinal; Ophthalmology; Diabetic retinopathy; Retinopathy; Visual acuity; Macular edema; Diabetes mellitus; Edema; Fluorescein angiography; Surgery; Endocrinology","score_opus":0.013145321724083066,"score_gpt":0.3169988850886186,"score_spread":0.30385356336453556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041345658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903902,0.007708632,0.00045814214,0.00011452822,0.000034301625,0.000043319287,0.00010172856,0.000053228116,0.0010958181],"genre_scores_gemma":[0.99452114,0.0031089454,0.00070418266,0.00009156086,0.000055233988,0.000034541186,0.00017032147,0.000009884612,0.0013042236],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999572,0.0000109638295,0.0000052484365,0.0000043535138,0.000010119232,0.000012045063],"domain_scores_gemma":[0.99989307,0.000026930185,0.000036400557,0.000005925657,0.000016261336,0.000021502172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013726391,0.00032167445,0.00029461537,0.00022961528,0.00011136503,0.00015033028,0.00015152532,0.00018532008,0.0022708771],"category_scores_gemma":[0.00022716138,0.00007628332,0.00013205734,0.00012348121,0.00016607014,0.00012983828,0.00010559317,0.00040177163,0.00030224808],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07214361,0.006249168,0.019903509,0.0019919516,0.00019616651,0.0008988025,0.00017102588,0.00059064367,0.55077714,0.00020158195,0.0015631907,0.3453132],"study_design_scores_gemma":[0.008386477,0.12720397,0.30229428,0.00029009988,0.0008774622,0.008064777,0.00041293364,0.0023499404,0.53262293,0.000344721,0.017111357,0.000041080966],"about_ca_topic_score_codex":0.00038728595,"about_ca_topic_score_gemma":0.00035802272,"teacher_disagreement_score":0.0022708771,"about_ca_system_score_codex":0.00008382656,"about_ca_system_score_gemma":0.00016150267,"threshold_uncertainty_score":0.0075968504},"labels":[],"label_agreement":null},{"id":"W2042598345","doi":"10.1089/jop.2011.0016","title":"Identification of Novel Competing β <sub>2</sub> AR Phospho-Extracellular Signal Regulated Kinase 1/2 Signaling Pathways in Human Trabecular Meshwork Cells","year":2011,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Adenylyl cyclase; Trabecular meshwork; Forskolin; MAPK/ERK pathway; Kinase; Signal transduction; Protein kinase A; Pertussis toxin; Agonist; Extracellular; Phosphorylation; Gs alpha subunit; Cell biology; Internal medicine; Endocrinology; Chemistry; Receptor; Biology; G protein; Medicine","score_opus":0.028713468352123534,"score_gpt":0.27213195917670047,"score_spread":0.24341849082457692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042598345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868466,0.005312016,0.003737356,0.00027678692,0.000058026988,0.00009266303,0.0012634478,0.00005972263,0.002353436],"genre_scores_gemma":[0.9867531,0.003415012,0.0042882464,0.00021915049,0.00006543907,0.00019084717,0.0025151893,0.000011473567,0.0025414783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998871,0.000010852422,0.000009875552,0.000025868434,0.000033608158,0.00003268935],"domain_scores_gemma":[0.99994767,0.0000070643755,0.000015835383,0.0000050471644,0.000012442832,0.00001193487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108321816,0.0002776008,0.00029753862,0.00028936606,0.00023906355,0.00041407745,0.00016778227,0.0002848651,0.0017304915],"category_scores_gemma":[0.00009534288,0.00015492814,0.00042052876,0.00029089735,0.00015566335,0.00021433608,0.000149015,0.000375044,0.0005153123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000255191,0.00003823069,0.00182085,0.00009184694,0.000011189022,0.00017516353,0.000033483415,0.000032863823,0.9954426,0.00010002519,0.00010433629,0.0018942115],"study_design_scores_gemma":[0.00024054512,0.0010829224,0.2302405,0.000035257453,0.00017987259,0.0037970387,0.00045517273,0.0023782344,0.74834335,0.0003921105,0.012828775,0.000026206259],"about_ca_topic_score_codex":0.0008240082,"about_ca_topic_score_gemma":0.0015236572,"teacher_disagreement_score":0.0017304915,"about_ca_system_score_codex":0.0003072523,"about_ca_system_score_gemma":0.0002551273,"threshold_uncertainty_score":0.005789101},"labels":[],"label_agreement":null},{"id":"W2042860514","doi":"10.1089/jop.2005.21.166","title":"Corneal Endothelial Deposits Associated with Rifabutin Use","year":2005,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Rifabutin; Medicine; Ophthalmology; Human immunodeficiency virus (HIV); Disease; Pathology; Immunology; Gastroenterology","score_opus":0.02538666850214851,"score_gpt":0.3098223255648104,"score_spread":0.2844356570626619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042860514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935958,0.0030697503,0.00058660033,0.00009829981,0.000012415616,0.000014595531,0.00003039279,0.00003616872,0.0025561121],"genre_scores_gemma":[0.9990802,0.00046459274,0.00016463721,0.00004539681,0.000035402005,0.0000024062251,0.000022809627,0.0000044496533,0.00018006143],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.999388,0.00013960125,0.00008446839,0.00008025513,0.00014717266,0.00016053683],"domain_scores_gemma":[0.99779886,0.00059019454,0.0011574848,0.00014207691,0.00016071151,0.0001506203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004484624,0.00042827416,0.00042579405,0.0008993633,0.000654419,0.0008968346,0.0003975046,0.0007547926,0.0020964923],"category_scores_gemma":[0.002292281,0.0002734569,0.00041351,0.0007045372,0.0006607698,0.0005133127,0.00040506397,0.0007013558,0.0004426341],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059596944,0.00010424372,0.5641813,0.00020151341,0.00010608201,0.4011074,0.00053097337,0.00022750319,0.015294857,0.00021675613,0.00033047536,0.017102858],"study_design_scores_gemma":[0.000026162397,0.0002734686,0.10499791,0.00004472831,0.00009037426,0.88568074,0.00030227538,0.0003292121,0.006591506,0.00008984259,0.0015589457,0.000014892079],"about_ca_topic_score_codex":0.00043427807,"about_ca_topic_score_gemma":0.00040223726,"teacher_disagreement_score":0.0020964923,"about_ca_system_score_codex":0.0002823957,"about_ca_system_score_gemma":0.00021877626,"threshold_uncertainty_score":0.0070134997},"labels":[],"label_agreement":null},{"id":"W2053497756","doi":"10.1089/jop.2006.125","title":"Safety Profile of Intravitreal Triamcinolone Acetonide","year":2007,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Medicine; Triamcinolone acetonide; Acetonide; Macular edema; Endophthalmitis; Central retinal vein occlusion; Surgery; Ophthalmology; Complication; Diabetic retinopathy; Visual acuity; Glaucoma; Diabetes mellitus","score_opus":0.020308907825277694,"score_gpt":0.35214221364697623,"score_spread":0.33183330582169857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053497756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846721,0.010953432,0.0014342306,0.00023257369,0.00002789712,0.000078042074,0.00019594122,0.00003305045,0.0023726928],"genre_scores_gemma":[0.99766374,0.0012050059,0.00044043417,0.0001480788,0.00008126262,0.000018525736,0.0001795094,0.000006023099,0.0002575332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999253,0.00021757584,0.00007069348,0.000053570173,0.00036816573,0.00003699599],"domain_scores_gemma":[0.9941294,0.0020268944,0.0026145335,0.0001978222,0.0007773867,0.0002538995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008826879,0.00017629137,0.0003998284,0.00034447762,0.0001808404,0.00042485952,0.00016357524,0.0003347528,0.0014882003],"category_scores_gemma":[0.0037204816,0.000059007038,0.00030233024,0.00027351922,0.00013807834,0.00015523721,0.000092714545,0.0003919975,0.0003158868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012759678,0.0014687553,0.4261485,0.001130323,0.00066390686,0.0032717308,0.0003518586,0.0011905867,0.14278795,0.00028307407,0.0013206071,0.40862304],"study_design_scores_gemma":[0.0010973315,0.09815824,0.7344972,0.0004253226,0.0014548481,0.05259414,0.0004470316,0.0058102533,0.08761377,0.00035801888,0.017479364,0.00006447905],"about_ca_topic_score_codex":0.00034952073,"about_ca_topic_score_gemma":0.00028821075,"teacher_disagreement_score":0.0014882003,"about_ca_system_score_codex":0.00023698501,"about_ca_system_score_gemma":0.00027913958,"threshold_uncertainty_score":0.0049785376},"labels":[],"label_agreement":null},{"id":"W2057683153","doi":"10.1089/jop.2009.0031","title":"Benzalkonium Chloride Enhances Antibacterial Activity of Gatifloxacin and Reduces its Propensity to Select for Fluoroquinolone-Resistant Strains","year":2009,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Gatifloxacin; Moxifloxacin; Levofloxacin; Benzalkonium chloride; Staphylococcus aureus; Microbiology; Medicine; Minimum inhibitory concentration; Chemistry; Pharmacology; Antimicrobial; Antibiotics; Chromatography; Biology; Bacteria","score_opus":0.03831685265093232,"score_gpt":0.3471052119290933,"score_spread":0.308788359278161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057683153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996822,0.0020778999,0.00033005307,0.00006742203,0.0000201806,0.00001659039,0.00007795083,0.00004014926,0.00054785324],"genre_scores_gemma":[0.9977336,0.0006802215,0.00077190716,0.0000631638,0.000016102584,0.000008644216,0.00012556078,0.000013572596,0.00058715726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995864,0.00010260904,0.000037986938,0.000055514087,0.00012631531,0.00009114156],"domain_scores_gemma":[0.99961,0.00006645121,0.00014653681,0.000023278768,0.00007463228,0.00007914989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017414487,0.00048364018,0.00048051064,0.00017140068,0.00010333549,0.00038279244,0.0002786134,0.00044489533,0.0009731937],"category_scores_gemma":[0.00045469758,0.00017715413,0.00019374171,0.00011022224,0.00025213696,0.00026869078,0.0002326407,0.00025196682,0.00039699336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005604682,0.000043915486,0.0007174019,0.00007234062,0.00000856921,0.000030807423,0.0000099745685,0.00004922952,0.9960859,0.0000109890525,0.000039432318,0.0023709682],"study_design_scores_gemma":[0.000065441825,0.004105013,0.01825474,0.0000227971,0.000046225476,0.00045659233,0.0000356731,0.0005342936,0.9746947,0.000018166318,0.0017502155,0.000016081945],"about_ca_topic_score_codex":0.0015999128,"about_ca_topic_score_gemma":0.0020010248,"teacher_disagreement_score":0.0015999128,"about_ca_system_score_codex":0.000302642,"about_ca_system_score_gemma":0.00025406698,"threshold_uncertainty_score":0.0032556653},"labels":[],"label_agreement":null},{"id":"W2058901144","doi":"10.1089/jop.2010.0150","title":"Enhanced Oxygen Saturation in Optic Nerve Head of Non-Human Primate Eyes Following the Intravitreal Injection of NCX 434, an Innovative Nitric Oxide-Donating Glucocorticoid","year":2011,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nickel Institute","funders":"National Institutes of Health; Ögonfonden; Research to Prevent Blindness","keywords":"Optic nerve; Intraocular pressure; Glucocorticoid; Medicine; Vasodilation; Ophthalmology; Nitric oxide; Glucocorticoid receptor; Retina; Chemistry; Anesthesia; Endocrinology; Biology","score_opus":0.03166162263058411,"score_gpt":0.3804430554613831,"score_spread":0.348781432830799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058901144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942297,0.0018958508,0.0007617212,0.000087126165,0.000050589922,0.000040452218,0.00034010087,0.000041177194,0.0025533524],"genre_scores_gemma":[0.9897119,0.0014444109,0.0021405388,0.00014713425,0.000033172597,0.000112356174,0.0008192695,0.000020214075,0.0055710613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998586,0.000014539414,0.0000058020405,0.00004028797,0.00004189634,0.00003876249],"domain_scores_gemma":[0.99986494,0.000022301361,0.00003899536,0.000015676549,0.00002439083,0.00003363499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021447917,0.00034547233,0.00023591863,0.0003803045,0.0003027652,0.0002840136,0.00022597154,0.00029186188,0.0013869916],"category_scores_gemma":[0.00016975695,0.00016809533,0.00023121064,0.00021054994,0.00048253065,0.0002737081,0.00012767101,0.0006261205,0.0002633548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013624997,0.00017424351,0.000585849,0.0000753384,0.000014155193,0.00023846877,0.00017516452,0.000046689405,0.9942841,0.00006691011,0.00011658528,0.0028600267],"study_design_scores_gemma":[0.00007763807,0.008243765,0.03424439,0.000022980475,0.00012367898,0.00079328404,0.00044431226,0.0012338907,0.9497443,0.00010427427,0.0049466477,0.000020879432],"about_ca_topic_score_codex":0.007296354,"about_ca_topic_score_gemma":0.008922804,"teacher_disagreement_score":0.007296354,"about_ca_system_score_codex":0.00049172866,"about_ca_system_score_gemma":0.0005744499,"threshold_uncertainty_score":0.014507771},"labels":[],"label_agreement":null},{"id":"W2063155750","doi":"10.1089/jop.2005.21.318","title":"Ketotifen Induces Primary Necrosis of Human Eosinophils","year":2005,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Tampereen Tuberkuloosisäätiö; Fondation pour la Recherche Médicale; Tays; Jalmari ja Rauha Ahokkaan Säätiö","keywords":"Ketotifen; Eosinophil; Immunology; Apoptosis; Medicine; Eosinophil cationic protein; Histamine; Tumor necrosis factor alpha; Leukotriene; Interleukin; Eosinophilia; Necrosis; Cytokine; Biology; Pathology; Pharmacology; Asthma","score_opus":0.026660115714571282,"score_gpt":0.3383953129095026,"score_spread":0.3117351971949313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063155750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901018,0.004887955,0.002040106,0.000107697364,0.000071289185,0.000101170575,0.0005336844,0.000039615115,0.0021167397],"genre_scores_gemma":[0.99499196,0.0018474433,0.0007715551,0.00009462541,0.000024104304,0.00004639611,0.0006478167,0.0000060882944,0.0015700888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977654,0.000067195586,0.000025185638,0.00002724048,0.000055958422,0.00004785684],"domain_scores_gemma":[0.9998779,0.00004609363,0.000021950389,0.000019663203,0.00001816313,0.000016207428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017926455,0.00028643486,0.0002801255,0.00011523504,0.00013211604,0.00016444114,0.00008837629,0.0001868148,0.0025075437],"category_scores_gemma":[0.00018669317,0.000067289526,0.00023713848,0.000098875425,0.00010220118,0.00012622999,0.00015289964,0.0003164728,0.00041962613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011118087,0.00013990527,0.0005234504,0.00015514604,0.000019083353,0.00042436234,0.00005938488,0.00009747756,0.9919429,0.00007691705,0.00019544258,0.005254187],"study_design_scores_gemma":[0.00015155952,0.003232314,0.009762638,0.00001951513,0.000035359448,0.0013070034,0.00008003873,0.000515982,0.9807488,0.000059783757,0.0040820665,0.000005046764],"about_ca_topic_score_codex":0.00032600007,"about_ca_topic_score_gemma":0.0006241757,"teacher_disagreement_score":0.0025075437,"about_ca_system_score_codex":0.0001372376,"about_ca_system_score_gemma":0.00012843723,"threshold_uncertainty_score":0.008388519},"labels":[],"label_agreement":null},{"id":"W2070340855","doi":"10.1089/108076802317373905","title":"Pharmacological and Molecular Biological (RT-PCR) Characterization of Functional TP Prostanoid Receptors in Immortalized Human Non-Pigmented Ciliary Epithelial Cells","year":2002,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Receptor; Prostanoid; Agonist; Phospholipase C; Receptor antagonist; Chemistry; Biology; Molecular biology; Antagonist; Endocrinology; Biochemistry","score_opus":0.022702669625970236,"score_gpt":0.2724968236606347,"score_spread":0.24979415403466448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070340855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9369387,0.0061795297,0.046758287,0.0002678667,0.0001759694,0.00040938548,0.004666031,0.00029293503,0.0043112882],"genre_scores_gemma":[0.94045633,0.0058217486,0.03342129,0.00024410446,0.00016473628,0.0007243145,0.011766965,0.00012046296,0.0072800703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995546,0.00007354608,0.00007448302,0.000088854315,0.00011892368,0.0000896169],"domain_scores_gemma":[0.9996767,0.00012397637,0.000038130216,0.000066246954,0.00006452236,0.000030527804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045943505,0.000423582,0.00041885197,0.0002850667,0.000220932,0.00051263865,0.00022663393,0.00028975282,0.0020829262],"category_scores_gemma":[0.00054541806,0.00019648479,0.0005718297,0.0003403151,0.00035380572,0.00026638314,0.00016408294,0.0008301807,0.0010690152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057412308,0.000019595911,0.00008748698,0.00003161656,0.0000040326495,0.00007177497,0.000016567496,0.000026022059,0.9989404,0.000060186692,0.000022189432,0.00066269387],"study_design_scores_gemma":[0.00003553454,0.000529159,0.007500617,0.000009903297,0.000056642653,0.00070335215,0.00006370929,0.0013032764,0.98520213,0.000080191894,0.004506873,0.0000086688715],"about_ca_topic_score_codex":0.00043442711,"about_ca_topic_score_gemma":0.00056490407,"teacher_disagreement_score":0.0020829262,"about_ca_system_score_codex":0.00020223585,"about_ca_system_score_gemma":0.0002814525,"threshold_uncertainty_score":0.0069680214},"labels":[],"label_agreement":null},{"id":"W2140318153","doi":"10.1089/jop.2010.0032","title":"Effectiveness of Dorzolamide–Timolol (COSOPT) in Patients Who Were Treatment Naive for Open-Angle Glaucoma or Ocular Hypertension: The COSOPT First-Line Study","year":2010,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Jewish General Hospital; Prism Eye Institute; Cégep Saint-Jean-sur-Richelieu; Montreal Heart Institute; McGill University; University of Calgary","funders":"","keywords":"Latanoprost; Dorzolamide; Medicine; Ocular hypertension; Timolol; Glaucoma; Intraocular pressure; Ophthalmology; Open angle glaucoma; Prostaglandin analogue; Population; Travoprost; Bimatoprost","score_opus":0.02759491475390569,"score_gpt":0.33723744303968656,"score_spread":0.30964252828578087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140318153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629223,0.0025188443,0.000039849947,0.00009534942,0.00002460691,0.00024233147,0.0002167027,0.000005657366,0.00056449434],"genre_scores_gemma":[0.99668866,0.001475716,0.00032522588,0.00032831536,0.0001459235,0.00014750933,0.00048305187,0.0000030517897,0.00040251404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994998,0.000172489,0.00003635468,0.00008815809,0.00012819246,0.000075054646],"domain_scores_gemma":[0.9989058,0.0002014476,0.0003128991,0.00004497734,0.00012340133,0.00041154373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009950153,0.00063675444,0.001642987,0.00027139232,0.00047487262,0.0006152569,0.0004622005,0.000801094,0.0017241036],"category_scores_gemma":[0.0011572328,0.0002697056,0.00095436064,0.0003875419,0.00049248646,0.00043018744,0.00019057133,0.0010942932,0.00024211232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52227956,0.044117972,0.2683043,0.002111729,0.0032272728,0.0009142073,0.00045725534,0.00072647404,0.021472163,0.00012282614,0.0024309733,0.1338353],"study_design_scores_gemma":[0.15725741,0.31305084,0.5196208,0.0001225185,0.0020396747,0.0011791363,0.00021974507,0.0013003333,0.0018949362,0.000037367347,0.003201252,0.00007595943],"about_ca_topic_score_codex":0.008190818,"about_ca_topic_score_gemma":0.024345258,"teacher_disagreement_score":0.008190818,"about_ca_system_score_codex":0.0016785319,"about_ca_system_score_gemma":0.0020022383,"threshold_uncertainty_score":0.016286254},"labels":[],"label_agreement":null},{"id":"W2144430913","doi":"10.1089/jop.2011.0041","title":"Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure","year":2011,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"AM251; Cannabinoid; Cannabidiol; Antagonist; Pharmacology; Agonist; Cannabinoid receptor type 2; Cannabinoid receptor antagonist; Cannabinoid receptor; Chemistry; Receptor antagonist; Medicine; Receptor; Internal medicine; Cannabis","score_opus":0.030800928270349345,"score_gpt":0.3228593906601688,"score_spread":0.2920584623898194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144430913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953551,0.0025654915,0.0009131042,0.00009044272,0.000036926926,0.000041997362,0.00011795549,0.000028205352,0.0008508198],"genre_scores_gemma":[0.9904545,0.0041649607,0.003115894,0.000111855974,0.000034704943,0.00006087179,0.00020039923,0.00000980158,0.0018469522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988365,0.000013859512,0.000008162893,0.000019878637,0.000038905786,0.000035644905],"domain_scores_gemma":[0.99986506,0.000018091361,0.000046263118,0.000011833315,0.000014117651,0.000044685217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012662228,0.00042153132,0.00033498876,0.0002948587,0.00017551566,0.00017129284,0.0002721964,0.00022839646,0.0012800315],"category_scores_gemma":[0.0001417859,0.00014623009,0.00027084508,0.00017950007,0.00031315393,0.00033598984,0.00015026421,0.0007247784,0.00017778718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013862655,0.0002966503,0.000817001,0.00007943472,0.000015934665,0.00014710022,0.000021753016,0.000058172358,0.99010605,0.00013142038,0.00005513539,0.0068852007],"study_design_scores_gemma":[0.00032474796,0.014547332,0.034721617,0.00001710196,0.00010987951,0.00090130675,0.00015412431,0.0012274305,0.9446606,0.00015450224,0.003153675,0.000027648362],"about_ca_topic_score_codex":0.0015040124,"about_ca_topic_score_gemma":0.004727122,"teacher_disagreement_score":0.0015040124,"about_ca_system_score_codex":0.00031197182,"about_ca_system_score_gemma":0.00037620333,"threshold_uncertainty_score":0.0042821765},"labels":[],"label_agreement":null},{"id":"W2723180213","doi":"10.1089/jop.2016.0195","title":"Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery","year":2017,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intertek (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Cornea; Inflammation; Dosing; Drug delivery; Implant; Anesthesia; Active metabolite; Placebo; Pharmacology; Ophthalmology; Surgery; Internal medicine; Pathology","score_opus":0.05417218397385774,"score_gpt":0.3506015106860727,"score_spread":0.29642932671221495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2723180213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811086,0.008049716,0.0051674363,0.00026875283,0.00008473006,0.0005191597,0.0005750747,0.00010056897,0.004125977],"genre_scores_gemma":[0.9870259,0.0046909302,0.003891082,0.00015036184,0.000033739925,0.00015411456,0.0010342018,0.000018438723,0.0030011975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970007,0.00006521271,0.000025062955,0.000054865923,0.00011157713,0.000043267508],"domain_scores_gemma":[0.9997837,0.000030281808,0.00007368082,0.000026254449,0.000046571997,0.000039515493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063284463,0.0005190005,0.0002746151,0.00026077082,0.00014327189,0.00043763153,0.00047201273,0.0004992482,0.002445945],"category_scores_gemma":[0.00031155185,0.00014148999,0.00041642223,0.00015503069,0.00036047818,0.00028879472,0.00015746448,0.0005324216,0.0005801633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012569679,0.00095264707,0.00074430136,0.0002626361,0.00002483135,0.00018820322,0.000047536105,0.00012354561,0.9708425,0.00013454845,0.00025063902,0.02517159],"study_design_scores_gemma":[0.001668989,0.11143338,0.023009146,0.00011090108,0.00021055446,0.0046784035,0.00013053889,0.0011792773,0.8425638,0.000087998786,0.014904883,0.000022065507],"about_ca_topic_score_codex":0.0007872056,"about_ca_topic_score_gemma":0.0014122933,"teacher_disagreement_score":0.002445945,"about_ca_system_score_codex":0.00037598083,"about_ca_system_score_gemma":0.00063861784,"threshold_uncertainty_score":0.008182466},"labels":[],"label_agreement":null},{"id":"W2738808279","doi":"10.1089/jop.2017.0037","title":"The <i>In Vivo</i> Effects of the CB <sub>1</sub> -Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice","year":2017,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health","keywords":"Intraocular pressure; Allosteric modulator; Agonist; Cannabinoid; Pharmacology; Ocular hypertension; Allosteric regulation; Medicine; Inverse agonist; Chemistry; In vivo; Ophthalmology; Receptor; Internal medicine; Biology","score_opus":0.006118364016720481,"score_gpt":0.25328302660147994,"score_spread":0.24716466258475947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738808279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881525,0.0011661499,0.0019464176,0.00052791246,0.00019355536,0.00009584436,0.0021760429,0.00039712782,0.004681693],"genre_scores_gemma":[0.98458916,0.0016331662,0.0038011852,0.00039878665,0.00006548751,0.00027871435,0.0014121351,0.00010038206,0.007720934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970466,0.000030107596,0.000029629913,0.00006481335,0.0000652753,0.00010546162],"domain_scores_gemma":[0.9997731,0.000018747647,0.000083488354,0.000024811901,0.000021960797,0.000077929544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019988992,0.00063276046,0.00050999195,0.00030166746,0.00027614817,0.000382818,0.00033372868,0.00046510153,0.0026902643],"category_scores_gemma":[0.00010361542,0.00026599687,0.0005500834,0.00020588447,0.00059496204,0.00041562255,0.0001514804,0.0017830388,0.0007183757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009948247,0.00021340132,0.00013531679,0.00006890273,0.000008213575,0.000054335425,0.000022323684,0.00005515609,0.99682873,0.00007865997,0.00021141738,0.0013286915],"study_design_scores_gemma":[0.00013331536,0.0022528723,0.003550902,0.000014860742,0.00004635312,0.00013096517,0.00006249045,0.0005416963,0.99157226,0.000052072344,0.0016290992,0.000013145487],"about_ca_topic_score_codex":0.0023835327,"about_ca_topic_score_gemma":0.0050094593,"teacher_disagreement_score":0.0026902643,"about_ca_system_score_codex":0.00052820845,"about_ca_system_score_gemma":0.0005001244,"threshold_uncertainty_score":0.0089998245},"labels":[],"label_agreement":null},{"id":"W2749059918","doi":"10.1089/jop.2017.0030","title":"The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma","year":2017,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Supine position; Trendelenburg position; Trendelenburg; Medicine; Sitting; Intraocular pressure; Open angle glaucoma; Hemodynamics; Blood pressure; Glaucoma; Anesthesia; Ophthalmology; Internal medicine","score_opus":0.005634322802313942,"score_gpt":0.26952440470697797,"score_spread":0.263890081904664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749059918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922013,0.00028588256,0.000034712462,0.000014792991,0.000009863301,0.000005662915,0.00006895646,0.0000018046057,0.00035816286],"genre_scores_gemma":[0.9997316,0.00008292104,0.000029343539,0.000013514934,0.0000091557085,0.000004199103,0.00007182175,5.642786e-7,0.000056822126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975914,0.000072818686,0.000029636727,0.000044343135,0.000057454483,0.0000366374],"domain_scores_gemma":[0.99931777,0.00012871777,0.00030895227,0.000030353403,0.000048443162,0.00016580339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018804253,0.0003091723,0.00034090612,0.00047041415,0.00028257963,0.00033147322,0.00010157897,0.00033511044,0.0013121775],"category_scores_gemma":[0.0011169682,0.00013071905,0.00028316784,0.000337734,0.00022008953,0.00019405654,0.00019799892,0.00022963891,0.0002110299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016274138,0.0001895768,0.9896225,0.00004815363,0.00010154991,0.00043653316,0.0002116286,0.00003102578,0.0023198863,0.00001040881,0.00008874157,0.0053127324],"study_design_scores_gemma":[0.000008030612,0.00039507102,0.9991825,0.0000026282478,0.000016540454,0.0002260865,0.000072372,0.000025552794,0.00004006061,0.000004258458,0.000025231166,0.0000015391622],"about_ca_topic_score_codex":0.0013038992,"about_ca_topic_score_gemma":0.0024766452,"teacher_disagreement_score":0.0013121775,"about_ca_system_score_codex":0.00019110212,"about_ca_system_score_gemma":0.000118207405,"threshold_uncertainty_score":0.0043896437},"labels":[],"label_agreement":null},{"id":"W2911499976","doi":"10.1089/jop.2018.0113","title":"Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Analgesic; Visual analogue scale; Anesthesia; Randomized controlled trial; Pain score; McGill Pain Questionnaire; Eye drop; Surgery; Ophthalmology","score_opus":0.023694708968159672,"score_gpt":0.3674040222902906,"score_spread":0.34370931332213095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911499976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827042,0.008082474,0.0009197233,0.0005890332,0.00076036796,0.0053129694,0.0004786808,0.000097800315,0.0010547074],"genre_scores_gemma":[0.9824353,0.004585919,0.0019902168,0.0010098007,0.0010475679,0.006884722,0.00042570345,0.00001697032,0.0016037644],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999079,0.00045471088,0.00008183146,0.00016852873,0.00009561137,0.00012032379],"domain_scores_gemma":[0.9984883,0.0005220007,0.0004236811,0.00010343773,0.00010672863,0.00035581112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021473682,0.001288145,0.004157347,0.0005026006,0.0005732163,0.0009999422,0.0010738033,0.002351231,0.006243395],"category_scores_gemma":[0.0019079183,0.0006751267,0.0017772747,0.000567167,0.0014712891,0.0008046489,0.0003278386,0.0019562254,0.00075406715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9792626,0.0075826347,0.00022387317,0.0006499668,0.00043526135,0.000027981838,0.000024400328,0.000080249054,0.002567595,0.000040092837,0.00018564677,0.0089195855],"study_design_scores_gemma":[0.9098316,0.08836169,0.0007782297,0.000029349263,0.00031792113,0.000018556302,0.0000117456575,0.00017306267,0.00026303003,0.00003441495,0.00017057305,0.00000990641],"about_ca_topic_score_codex":0.0007645634,"about_ca_topic_score_gemma":0.0016624026,"teacher_disagreement_score":0.006243395,"about_ca_system_score_codex":0.0006004228,"about_ca_system_score_gemma":0.0012936908,"threshold_uncertainty_score":0.020886302},"labels":[],"label_agreement":null},{"id":"W2914349717","doi":"10.1089/jop.2018.0090","title":"Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States","year":2019,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Uveitis; Medical record; Dosing; Retrospective cohort study; Concomitant; Internal medicine; Pediatrics; Ophthalmology","score_opus":0.016216434582006035,"score_gpt":0.2904205326921129,"score_spread":0.2742040981101068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914349717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92398626,0.02809598,0.0005677056,0.00047866968,0.00005875891,0.0010140006,0.037459385,0.00004546776,0.0082938215],"genre_scores_gemma":[0.98325217,0.0055764415,0.0006821442,0.00050107966,0.00006239734,0.0005327818,0.009109266,0.000010503815,0.00027334102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603903,0.0008123538,0.0016653872,0.0005189112,0.00073797686,0.0002263037],"domain_scores_gemma":[0.98004526,0.0053780074,0.011954518,0.0005632589,0.0017135842,0.00034534122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016880713,0.00020454181,0.0006999059,0.0038633638,0.000648085,0.0008538972,0.0005036783,0.00050195545,0.0026219795],"category_scores_gemma":[0.010935415,0.00026504704,0.0006006019,0.0075735166,0.0003344281,0.0007398084,0.00050651643,0.00042893708,0.00038133535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017161029,0.00005140576,0.9891388,0.0009892368,0.00014071263,0.0007344789,0.00036477373,0.000045096087,0.00013966755,0.00006786183,0.001898019,0.0062582293],"study_design_scores_gemma":[0.000047839923,0.000153552,0.98790866,0.0010541308,0.000203886,0.0034095247,0.0011211836,0.0001974537,0.00025738208,0.000040957642,0.0055897455,0.000015697473],"about_ca_topic_score_codex":0.010409272,"about_ca_topic_score_gemma":0.010248892,"teacher_disagreement_score":0.010409272,"about_ca_system_score_codex":0.0012643026,"about_ca_system_score_gemma":0.002351448,"threshold_uncertainty_score":0.020697355},"labels":[],"label_agreement":null},{"id":"W2939710496","doi":"10.1089/jop.2018.0136","title":"Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%","year":2019,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health","keywords":"Chromatography; Dissolution; Chemistry; Pharmacokinetics; Rheology; Bioavailability; Materials science; Pharmacology; Medicine","score_opus":0.02204183097643648,"score_gpt":0.28428428335358147,"score_spread":0.262242452377145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939710496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797493,0.0012282671,0.00042881197,0.000025924342,0.000004588727,0.000016078731,0.00006756384,0.0000091860575,0.00024462034],"genre_scores_gemma":[0.9970688,0.0007827664,0.0012800501,0.000035581557,0.0000045650586,0.000026338306,0.00010429656,0.00000540639,0.00069229095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999114,0.000020400706,0.000008262495,0.000017015218,0.00003152361,0.000011460928],"domain_scores_gemma":[0.999877,0.00003112439,0.000054468066,0.0000075536113,0.000014965767,0.0000148380495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022691525,0.00022946383,0.00015904712,0.00014564522,0.000050773004,0.00013743679,0.000090187554,0.00016377095,0.0006136192],"category_scores_gemma":[0.000327989,0.00009146164,0.000107022905,0.00007287296,0.000116921685,0.00023389907,0.00007863314,0.000217493,0.00011288949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084490207,0.00007149348,0.0008823987,0.00005265027,0.000008534136,0.00004999367,0.000022916463,0.00009392471,0.99146116,0.000017330718,0.0000375685,0.0064570378],"study_design_scores_gemma":[0.0001418397,0.012509959,0.026760131,0.00001832468,0.00007246024,0.00054914673,0.000058942293,0.0018542182,0.9560587,0.000029159415,0.001935268,0.000011843981],"about_ca_topic_score_codex":0.0007622064,"about_ca_topic_score_gemma":0.00086691306,"teacher_disagreement_score":0.0007622064,"about_ca_system_score_codex":0.0002545439,"about_ca_system_score_gemma":0.00017154505,"threshold_uncertainty_score":0.002052784},"labels":[],"label_agreement":null},{"id":"W2943895833","doi":"10.1089/jop.2019.0013","title":"Fluoroquinolone Antibiotic Prophylaxis to Prevent Post-Traumatic Bacterial Infectious Endophthalmitis: Using Monte Carlo Simulation to Evaluate the Probability of Success","year":2019,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Waterloo; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Levofloxacin; Dosing; Moxifloxacin; Medicine; Ciprofloxacin; Endophthalmitis; Pharmacokinetics; Pharmacodynamics; Antibiotics; Pharmacology; Surgery; Microbiology; Biology","score_opus":0.0329808119425686,"score_gpt":0.3571982934972295,"score_spread":0.3242174815546609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943895833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90704346,0.0020595903,0.083929524,0.0005166432,0.00003850528,0.00034125845,0.000570767,0.00028140956,0.005218945],"genre_scores_gemma":[0.98924506,0.00030459903,0.009699614,0.00006652036,0.0000128608535,0.00015434268,0.00017183655,0.000011848108,0.00033336712],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991762,0.00046769626,0.000047808036,0.000092133596,0.00015209192,0.000064084685],"domain_scores_gemma":[0.984056,0.013760989,0.0012077694,0.00026167466,0.0005407883,0.00017268806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024467958,0.00055012613,0.0009231735,0.0012341412,0.00031572935,0.0007615504,0.00081162,0.0010237128,0.0014118025],"category_scores_gemma":[0.011511117,0.00047882917,0.0010203054,0.00053526036,0.00039639982,0.0004269335,0.00034823755,0.0005053046,0.00012726588],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025955588,0.00008277553,0.010627465,0.000062883,0.00012879557,0.000047227546,0.000026910724,0.9828622,0.00054506416,0.0009971776,0.00016653673,0.0041934126],"study_design_scores_gemma":[0.000029828483,0.00012825406,0.0012054631,0.000014409978,0.00003091869,0.00002611757,0.0000067850215,0.9977367,0.00031750483,0.00038588964,0.0001115574,0.0000065854065],"about_ca_topic_score_codex":0.017841535,"about_ca_topic_score_gemma":0.008867495,"teacher_disagreement_score":0.017841535,"about_ca_system_score_codex":0.0016752015,"about_ca_system_score_gemma":0.0016494871,"threshold_uncertainty_score":0.035475373},"labels":[],"label_agreement":null},{"id":"W2966212753","doi":"10.1089/jop.2019.0019","title":"Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery","year":2019,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Dalhousie University; McGill University","funders":"","keywords":"Medicine; Synechia; Intraocular pressure; Corticosteroid; Glaucoma; Visual acuity; Concomitant; Surgery; Prospective cohort study; Ophthalmology; Anesthesia","score_opus":0.007401122555167888,"score_gpt":0.28521918185160433,"score_spread":0.27781805929643644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966212753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990988,0.0006829123,0.000020984508,0.000011360849,0.0000048731267,0.000004200229,0.000016493816,8.244831e-7,0.000159564],"genre_scores_gemma":[0.9997373,0.00015670461,0.000025679412,0.000009421097,0.000012008743,0.0000023399853,0.00002508663,2.8210417e-7,0.00003105636],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996093,0.000076867116,0.000064534564,0.000044917848,0.00011747895,0.00008684664],"domain_scores_gemma":[0.9984952,0.000348397,0.0007784044,0.000048018,0.000103893515,0.00022603314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031534428,0.00016998145,0.00038567424,0.00042822273,0.00023431022,0.00033418555,0.00013158083,0.00023877154,0.0009753742],"category_scores_gemma":[0.0014742996,0.00008330048,0.00040530477,0.00039268832,0.00026696842,0.0002771626,0.0002178886,0.00030678837,0.000105400824],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021048675,0.0002136614,0.983597,0.00005364303,0.0001351369,0.002255663,0.000046451278,0.000032366795,0.0017410684,0.000013984895,0.00004117864,0.009765011],"study_design_scores_gemma":[0.000044904107,0.0021914947,0.99043816,0.00002167432,0.00012427094,0.0061503327,0.00023262744,0.000113033275,0.0005199801,0.000015602913,0.00014247678,0.0000054805914],"about_ca_topic_score_codex":0.0005837109,"about_ca_topic_score_gemma":0.0015499642,"teacher_disagreement_score":0.0009753742,"about_ca_system_score_codex":0.00024559465,"about_ca_system_score_gemma":0.00038384486,"threshold_uncertainty_score":0.003262937},"labels":[],"label_agreement":null},{"id":"W2986847555","doi":"10.1089/jop.2019.0064","title":"From Engineered Tissues and Microfludics to Human Eyes-On-A-Chip","year":2019,"lang":"en","type":"editorial","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; California HIV/AIDS Research Program","keywords":"Library science; Engineering; Computer science","score_opus":0.01917782579342939,"score_gpt":0.3490663752510837,"score_spread":0.3298885494576543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986847555","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013708176,0.016021043,0.0005436842,0.026020614,0.9545278,0.000030436519,0.000059524402,0.00008445612,0.0025753672],"genre_scores_gemma":[0.0024691047,0.029388055,0.0007574452,0.04830878,0.8645254,0.000095707815,0.00010671014,0.000106749314,0.054242138],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970381,0.0004073841,0.00032108073,0.00025591176,0.0017798669,0.00019773102],"domain_scores_gemma":[0.9954216,0.0023941088,0.0002784711,0.00014327385,0.001194979,0.00056753034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034467538,0.0022975958,0.0016944637,0.0016895336,0.0014808471,0.004880093,0.0024981818,0.012338425,0.009767734],"category_scores_gemma":[0.0073132077,0.001267032,0.0015916926,0.00058581267,0.001709268,0.0028121758,0.0017894948,0.016009184,0.005348943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000929505,0.000024846404,0.00001766841,0.00045237233,0.000023536892,0.00024348192,0.000017042566,0.00006380394,0.0012059226,0.0011801518,0.9788522,0.017825974],"study_design_scores_gemma":[0.00006664654,0.00005111503,0.0001192304,0.00017647614,0.0000372248,0.00020521162,0.000017528766,0.00019541189,0.0013461951,0.0010864182,0.99668354,0.0000148556865],"about_ca_topic_score_codex":0.0010634926,"about_ca_topic_score_gemma":0.0039219907,"teacher_disagreement_score":0.012338425,"about_ca_system_score_codex":0.0019419085,"about_ca_system_score_gemma":0.0015598818,"threshold_uncertainty_score":0.03267634},"labels":[],"label_agreement":null},{"id":"W3037331797","doi":"10.1089/jop.2020.0038","title":"Changes in Aqueous Cytokine Levels Following Intravitreal Aflibercept in Treatment-Naive Patients with Diabetic Macular Edema","year":2020,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health; Hospital for Sick Children; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Medicine; Aflibercept; Placental growth factor; Cytokine; Vascular endothelial growth factor; Hepatocyte growth factor; Growth factor; Internal medicine; Gastroenterology; Bevacizumab; Receptor; VEGF receptors; Chemotherapy","score_opus":0.025095385341584217,"score_gpt":0.3076539976487917,"score_spread":0.28255861230720747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037331797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995332,0.00023206286,0.000028742657,0.000011410708,0.000003228523,0.000008892451,0.000050310988,0.0000017351753,0.00013052813],"genre_scores_gemma":[0.99955446,0.000078247955,0.00006958343,0.000038877442,0.00001114328,0.000014033837,0.00012075015,8.286587e-7,0.000112030095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966276,0.00008929609,0.000045933,0.00007065856,0.00007149323,0.000059873764],"domain_scores_gemma":[0.99906904,0.00016223958,0.0005181611,0.00003558113,0.00007231811,0.0001426814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038083512,0.00025976208,0.00052194664,0.0003272004,0.00028009797,0.00045279492,0.00017015803,0.00041537613,0.000851199],"category_scores_gemma":[0.001190876,0.00015749513,0.00031970092,0.00035504645,0.00016177456,0.00034513455,0.0001583053,0.00041470572,0.00018875048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035281056,0.0004475971,0.981835,0.000045203848,0.000099359124,0.0007298865,0.000116169445,0.00006074779,0.006343917,0.000009187284,0.000091830756,0.006692844],"study_design_scores_gemma":[0.00012766688,0.0029422892,0.9943837,0.000007620876,0.000057664773,0.0012835425,0.00010176753,0.000129562,0.00071223127,0.000010256487,0.0002366437,0.0000070328297],"about_ca_topic_score_codex":0.0006256862,"about_ca_topic_score_gemma":0.0009104923,"teacher_disagreement_score":0.000851199,"about_ca_system_score_codex":0.00030536496,"about_ca_system_score_gemma":0.00017913742,"threshold_uncertainty_score":0.0028474927},"labels":[],"label_agreement":null},{"id":"W3143366754","doi":"10.1089/jop.2020.0089","title":"Pre-Emptive Topical Ketorolac Tromethamine 0.5% for Panretinal Photocoagulation","year":2021,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ketorolac Tromethamine; Medicine; Ketorolac; Placebo; Eye drop; Visual analogue scale; Anesthesia; Diabetic retinopathy; Panretinal photocoagulation; Ophthalmology; Surgery; Diabetes mellitus; Analgesic","score_opus":0.031490742655392215,"score_gpt":0.38164281693196994,"score_spread":0.35015207427657774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143366754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956714,0.0031348222,0.0003377834,0.000054237673,0.000060717826,0.00040440838,0.000039970848,0.00001727579,0.00027923222],"genre_scores_gemma":[0.99698275,0.001267127,0.0008440484,0.00014916123,0.00012853586,0.00035279943,0.000093051014,0.000003682742,0.00017878588],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993994,0.00026956902,0.00008514468,0.00008813831,0.00009221088,0.00006550721],"domain_scores_gemma":[0.9992655,0.00026171326,0.00021539406,0.0000561657,0.000051662144,0.00014959833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010572855,0.00057982834,0.0014582792,0.00026314546,0.000327703,0.00034538604,0.00037131816,0.0005139516,0.001458595],"category_scores_gemma":[0.0015702387,0.0002706476,0.00058761437,0.00017350691,0.00046512173,0.00034965717,0.00019830387,0.0008047896,0.00025913405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56229395,0.03782125,0.017773697,0.002249569,0.0007572255,0.0006581437,0.00025389798,0.00059022434,0.19563901,0.000094208706,0.00071340974,0.1811554],"study_design_scores_gemma":[0.09921101,0.8386657,0.043431938,0.00008977014,0.00066636293,0.00089985935,0.00008977083,0.0006111156,0.015014315,0.00003928921,0.0012500985,0.000030759238],"about_ca_topic_score_codex":0.00025718857,"about_ca_topic_score_gemma":0.0006658961,"teacher_disagreement_score":0.001458595,"about_ca_system_score_codex":0.00019745067,"about_ca_system_score_gemma":0.00051917176,"threshold_uncertainty_score":0.0055915117},"labels":[],"label_agreement":null},{"id":"W4200015017","doi":"10.1089/jop.2021.0091","title":"Mucoadhesive Polymers Enhance Ocular Drug Delivery: Proof of Concept Study with 0.5% Tropicamide in Dogs","year":2021,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tropicamide; Medicine; Anesthesia; Drug administration; Clinical trial; Ophthalmology; Pharmacology; Internal medicine; Pupil","score_opus":0.0377394393139188,"score_gpt":0.38321570884888745,"score_spread":0.3454762695349686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200015017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527776,0.0021910595,0.0018814089,0.00007443331,0.000020297688,0.00016688328,0.000089352674,0.000035809328,0.00026307383],"genre_scores_gemma":[0.99112904,0.0021796727,0.005802837,0.000043277993,0.00002222773,0.000108296306,0.00015050746,0.0000109558705,0.00055320706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975795,0.000072744326,0.000014507895,0.000039999024,0.0000667777,0.000048078495],"domain_scores_gemma":[0.99976045,0.00005637656,0.0000886494,0.000014529462,0.000032605574,0.00004734853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067000784,0.00034689656,0.0004452547,0.00022253198,0.000104751045,0.00029516616,0.00038159135,0.00038519673,0.00045870492],"category_scores_gemma":[0.00037797395,0.00017370506,0.0003001856,0.00013136759,0.00029230717,0.0004957864,0.00016029664,0.00037263733,0.00012504707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014007061,0.00080840057,0.0003476846,0.00025106606,0.000026681697,0.00008531551,0.00005328907,0.00029710834,0.98767275,0.000048938957,0.00010325362,0.008904669],"study_design_scores_gemma":[0.0005285406,0.082452245,0.011383481,0.000036795172,0.00018601427,0.000530016,0.00009490709,0.0025565915,0.8977504,0.000031713644,0.004432161,0.00001709223],"about_ca_topic_score_codex":0.0006995345,"about_ca_topic_score_gemma":0.0009822564,"teacher_disagreement_score":0.0006995345,"about_ca_system_score_codex":0.000362305,"about_ca_system_score_gemma":0.00021644704,"threshold_uncertainty_score":0.0035433173},"labels":[],"label_agreement":null},{"id":"W4200048207","doi":"10.1089/jop.2021.0084","title":"Comparisons of α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats","year":2021,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; UK Research and Innovation; Invest Northern Ireland; Medical Research Council; University of South Carolina","keywords":"Medetomidine; Xylazine; Medicine; Pentobarbital; Anesthesia; Adrenergic; Ketamine; Internal medicine; Receptor; Blood pressure; Heart rate","score_opus":0.02494992361294003,"score_gpt":0.3128921785877921,"score_spread":0.2879422549748521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200048207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819355,0.0057031456,0.009469347,0.00039420387,0.00021141623,0.00034810588,0.00044593046,0.00011700505,0.0013753353],"genre_scores_gemma":[0.96317357,0.0044668466,0.02831949,0.0006264857,0.00011605054,0.0008899071,0.0007409594,0.00007858658,0.0015880817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841917,0.00044060335,0.0003418685,0.00024761306,0.00038064044,0.00017013929],"domain_scores_gemma":[0.9988495,0.00023826615,0.00039686775,0.00020269191,0.00016200033,0.00015061433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020867118,0.00069124764,0.0007508329,0.0006973526,0.00035624907,0.0005784643,0.0005546195,0.00063218386,0.00073013833],"category_scores_gemma":[0.0011244382,0.0002936437,0.0004688002,0.0005452803,0.0009109053,0.00078181224,0.0003208943,0.001289477,0.00016914442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063538845,0.0007257588,0.0044032624,0.0003056022,0.000087986155,0.00026960863,0.00016804266,0.00016407766,0.9736275,0.00034805475,0.00015847829,0.0133877145],"study_design_scores_gemma":[0.0003229251,0.012826425,0.036798984,0.00010686776,0.00022826975,0.0009770428,0.0003865206,0.0010240208,0.9432074,0.00031558538,0.0037727696,0.000033189604],"about_ca_topic_score_codex":0.0007505543,"about_ca_topic_score_gemma":0.0027699196,"teacher_disagreement_score":0.0020867118,"about_ca_system_score_codex":0.0004049873,"about_ca_system_score_gemma":0.0005280396,"threshold_uncertainty_score":0.01103574},"labels":[],"label_agreement":null},{"id":"W4376637080","doi":"10.1089/jop.2022.0185","title":"Trends in Ophthalmological Patents, 2005–2020","year":2023,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Biomedical Imaging and Bioengineering","keywords":"Medicine; Trademark; Ophthalmology; Optometry; Political science; Law","score_opus":0.054083883531969454,"score_gpt":0.3776644980134521,"score_spread":0.3235806144814826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376637080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5220348,0.15566632,0.0018941478,0.0108838845,0.000638883,0.00017548159,0.27589473,0.0006048791,0.0322068],"genre_scores_gemma":[0.8585702,0.043715037,0.0021198108,0.0019350185,0.0007583198,0.00021001822,0.08778092,0.000068181704,0.004842416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646133,0.0002698416,0.00087972364,0.00077994703,0.0012466016,0.00036263332],"domain_scores_gemma":[0.973724,0.006191077,0.01338735,0.000306457,0.0053777164,0.0010133071],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0030585201,0.0004172213,0.00056918105,0.016569765,0.00043517526,0.0036673083,0.0007872525,0.0009350659,0.0044226656],"category_scores_gemma":[0.02000342,0.00016866304,0.0013064743,0.023255602,0.00045591439,0.0030272824,0.0010044302,0.0011727063,0.0014988518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000998776,0.0001892278,0.6679238,0.0075752973,0.0011761081,0.0008819304,0.0009319423,0.0027305032,0.0013364195,0.009163122,0.108417615,0.19867529],"study_design_scores_gemma":[0.000071078764,0.0003311712,0.88166213,0.0015636694,0.000656763,0.0019587434,0.0009799422,0.0025727842,0.0011249136,0.0009010971,0.108126506,0.000051120147],"about_ca_topic_score_codex":0.017588869,"about_ca_topic_score_gemma":0.015311638,"teacher_disagreement_score":0.9834302,"about_ca_system_score_codex":0.0026154898,"about_ca_system_score_gemma":0.0029238667,"threshold_uncertainty_score":0.034972966},"labels":[],"label_agreement":null},{"id":"W4394759580","doi":"10.1089/jop.2024.0017","title":"Diagnostic Uses of Common Eye Drops","year":2024,"lang":"en","type":"review","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital","funders":"","keywords":"Eye drop; Medicine; Eye care; Mydriatics; Optometry; Diagnostic test; Eye disease; Intensive care medicine; Ophthalmology; Pupil; Psychology; Pediatrics; Neuroscience","score_opus":0.05500034013822575,"score_gpt":0.4394127020879642,"score_spread":0.38441236194973843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394759580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053650356,0.9950244,0.00026809602,0.00035348063,0.00022541377,0.000012229957,0.00004179764,0.00001071322,0.0035273815],"genre_scores_gemma":[0.0063753906,0.99090815,0.0006853605,0.00044499736,0.0002846149,0.000015423466,0.000072878676,0.0000033652186,0.0012097891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899906,0.00017383431,0.0001682997,0.00013476565,0.0004599845,0.00006410003],"domain_scores_gemma":[0.9994192,0.0003008005,0.00009471563,0.000018695526,0.00014458063,0.000022009832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060520525,0.0006253783,0.0008579595,0.003535683,0.00034414575,0.0010742248,0.00069942116,0.000888096,0.004076252],"category_scores_gemma":[0.001484372,0.00015629023,0.00077856996,0.0018325993,0.0005628223,0.0011697966,0.00065406266,0.0011422677,0.0010595457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010376649,0.000074125615,0.000833391,0.021093275,0.00013525727,0.0008272588,0.00022067988,0.00015170447,0.0033728331,0.004643284,0.01585881,0.9526856],"study_design_scores_gemma":[0.00002046599,0.00015838142,0.0033259839,0.010154447,0.00021032174,0.011301429,0.0002821909,0.00013973805,0.00318458,0.0024464724,0.9687427,0.000033074608],"about_ca_topic_score_codex":0.0013721975,"about_ca_topic_score_gemma":0.0020560464,"teacher_disagreement_score":0.004076252,"about_ca_system_score_codex":0.0006082078,"about_ca_system_score_gemma":0.0009657784,"threshold_uncertainty_score":0.01363641},"labels":[],"label_agreement":null},{"id":"W4401764133","doi":"10.1089/jop.2024.0071","title":"Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection","year":2024,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chlorhexidine gluconate; Sterility; Chlorhexidine; Medicine; Surgery; Term (time); Dentistry; Biology","score_opus":0.049411887477773815,"score_gpt":0.3976247473891121,"score_spread":0.34821285991133827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401764133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995752,0.0032346311,0.00034245246,0.00006691003,0.000017300685,0.00003670303,0.0000948612,0.000008358751,0.0004467858],"genre_scores_gemma":[0.9981932,0.0006404689,0.0005953952,0.00003297497,0.000013020387,0.000017339971,0.00014748369,0.0000047192575,0.00035541097],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985532,0.0003415463,0.00011719311,0.00015324914,0.0007102612,0.0001243765],"domain_scores_gemma":[0.99796045,0.00037015654,0.0008863409,0.00010808093,0.00050370395,0.00017134311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012088795,0.00028737664,0.0002761234,0.0005045432,0.00023176044,0.00077279145,0.00049898325,0.0004411518,0.0015209247],"category_scores_gemma":[0.0021713132,0.00011736873,0.0004869595,0.00044046895,0.00028343688,0.00048407068,0.00033928725,0.00033124452,0.0002470312],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01564832,0.0044765733,0.11301122,0.0010693283,0.0006245331,0.00061611197,0.00027379437,0.003722414,0.6082403,0.0003062412,0.0008999205,0.25111133],"study_design_scores_gemma":[0.00038738124,0.10453363,0.33895096,0.0003079382,0.0012427189,0.0022455503,0.00086321647,0.00956284,0.534846,0.00015999666,0.00675698,0.00014274585],"about_ca_topic_score_codex":0.0022344943,"about_ca_topic_score_gemma":0.0031030227,"teacher_disagreement_score":0.0022344943,"about_ca_system_score_codex":0.0015054137,"about_ca_system_score_gemma":0.0006188166,"threshold_uncertainty_score":0.010922611},"labels":[],"label_agreement":null},{"id":"W4403124582","doi":"10.1089/jop.2024.0113","title":"Clinical Pharmacokinetics of Atropine Administered Ocularly Using an Ultrasensitive Bioanalytical Assay","year":2024,"lang":"en","type":"article","venue":"Journal of Ocular Pharmacology and Therapeutics","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Bioanalysis; Pharmacokinetics; Pharmacology; Atropine; Medicine; Chemistry; Chromatography; Internal medicine","score_opus":0.09576741657826439,"score_gpt":0.4479273689707179,"score_spread":0.3521599523924535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403124582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96969193,0.007636449,0.020030942,0.00021829554,0.00004157812,0.00022783683,0.00018694898,0.00020673266,0.0017592213],"genre_scores_gemma":[0.99049324,0.0011991112,0.0072189835,0.00018809292,0.00003743863,0.00007142321,0.00007884242,0.000012331394,0.0007004977],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99921787,0.00029013646,0.000035037727,0.00013793295,0.00029465932,0.000024323448],"domain_scores_gemma":[0.9994603,0.00017199777,0.0002066721,0.000042362244,0.0000806378,0.000038041773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007393989,0.0002793768,0.0003169067,0.00023016281,0.00017805521,0.00038914505,0.00014966476,0.00029446316,0.00060583866],"category_scores_gemma":[0.001022847,0.00016928496,0.00012635849,0.0002107325,0.0004684265,0.00026800792,0.00011369443,0.0005536616,0.00023812406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002891399,0.0003104442,0.029333666,0.00018683341,0.00009983568,0.00024462928,0.00021282013,0.00054770167,0.8947473,0.00012879643,0.0003947638,0.070901796],"study_design_scores_gemma":[0.00039647063,0.02172085,0.31065437,0.000066047185,0.00025185238,0.00379475,0.0002630475,0.013883253,0.6430977,0.00019842132,0.00560447,0.00006876793],"about_ca_topic_score_codex":0.0011706516,"about_ca_topic_score_gemma":0.001461121,"teacher_disagreement_score":0.0011706516,"about_ca_system_score_codex":0.0003491098,"about_ca_system_score_gemma":0.00044395108,"threshold_uncertainty_score":0.0039103627},"labels":[],"label_agreement":null}]}